Vermont Gift Ban Tamps Down Pharma’s Non-research Spending

Dec. 9, 2013 – A recent report from Vermont Attorney General William H. Sorrell provides some insight into the impact a prescribed products gift ban in that state has had on pharmaceutical companies’ non-research spending, according to a recent article in Policy and Medicine.

The Vermont AG’s report “reflects amendments made to the state’s gift ban and disclosure law in 2009 and 2011” and notes that “these changes in the law complicate the comparison of data from year to year.” However, pharmaceutical expenditures excluding clinical trials and research are listed as roughly $1.2 million for 2012, down from approximately $2.9 million in 2011, the report data show.

To read the full Policy and Medicine article, go to: antibiotic